Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Imiquimod 5% cream with photodynamic therapy for actinic cheilitis has completed. The sponsor is the Norwegian University of Sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod 5% cream (Imiquimod)
  • Photodynamic Therapy

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Actinic Cheilitis | Phase 4 | Status: COMPLETED